Tag: CLSN News


Celsion GmbH, A Subsidiary Of Celsion Corporation (NASDAQ: CLSN), Enrolls Subjects In Phase I PanDox Clinical Trial To Treat Patients Suffering From Pancreatic Cancer

Celsion GmbH, a wholly-owned auxiliary of Celsion Corporation (NASDAQ: CLSN), commences enrollment in Phase I PanDox clinical trial using ThermoDox and FUS (Focused Ultrasound)¬†patients to cure pancreatic cancer.¬† MHRA gives the nod for clinical trial The oxford university-sponsored investigator-led clinical trial supported by NIHR (National Institute for Health Research) received […]